Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2020

Jul 28, 2020

29809_dirs_2020-07-28_1d2bd5d3-a983-4e92-9d79-8840463c052a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2020-07-24

Reporting Person: DeSantis Robert (Executive VP & GM IA&E)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-24 Common Stock S 1033 $666.6872 Disposed 3348 Direct
2020-07-24 Common Stock M 382 $230.9967 Acquired 3730 Direct
2020-07-24 Common Stock S 382 $665.5686 Disposed 3348 Direct
2020-07-24 Common Stock M 383 $178.3867 Acquired 3731 Direct
2020-07-24 Common Stock S 383 $665.5686 Disposed 3348 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-24 Non-Qualified Stock Option (right to buy) $178.3867 M 383 Disposed 2026-02-16 Common Stock (383) Direct
2020-07-24 Non-Qualified Stock Option (right to buy) $ M 382 Disposed 2026-08-15 Common Stock (382) Direct

Footnotes

F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

F2: The average selling price for the transaction was $666.687162. The shares sold at $663.33-$663.42 = 300 shares; $664.75 - $664.84 = 200 shares; $665.13 = 17 shares; $667.65 = 100 shares; $668 = 100 shares; $670.133 - $670.65 = 316 shares.

F3: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares.

F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

F5: The exercise price to the shares underlying this grant is $230.9967, equal to 100% of the closing FMV of the Company on the date of grant.